product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
RhoGDI Antibody
catalog :
2564
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat, cow
application :
western blot, immunocytochemistry, flow cytometry
more info or order :
Cell Signaling Technology product webpage
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; fig 5
Peda J, Salah S, Wallace D, Fields P, Grantham C, Fields T, et al. Autocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney disease. Dis Model Mech. 2016;9:1051-61 pubmed publisher
Müllers E, Silva Cascales H, Jaiswal H, Saurin A, Lindqvist A. Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase. Cell Cycle. 2014;13:2733-43 pubmed publisher
Marjoram R, Li Z, He L, Tollefsen D, Kunicki T, Dickeson S, et al. α2β1 integrin, GPVI receptor, and common FcRγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis. PLoS ONE. 2014;9:e114035 pubmed publisher
Yu M, Sun J, Peng W, Chen Z, Lin X, Liu X, et al. Protein expression in human trabecular meshwork: downregulation of RhoGDI by dexamethasone in vitro. Mol Vis. 2010;16:213-23 pubmed
product information
SKU :
2564S
Product-Name :
RhoGDI Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, B
Applications :
Flow cytometry
Product-Category :
Cytoskeletal Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
26 kDa
Host :
Rabbit
Target :
RhoGDI alpha
Primary-Protein :
RhoGDI alpha
Alt-Names :
ARHGDIA,GDIA1,GDIR1,MGC117248,RHOGDI,RHOGDI-1,Rho GDI 1,Rho GDP dissociation inhibitor (GDI) alpha,Rho GDP-dissociation inhibitor 1,Rho-GDI alpha
more info or order :
Cell Signaling Technology product webpage
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.